
12/08/2025
Two weeks, more than 700 urine samples, and over 120,000 measurement points 🔥
In July, our team joined forces with researchers from Shanghai and Nanjing. Together, we replicated years of learnings from our Finnish prostate cancer studies.
The results will help confirm that our phage-biosensor technology works across genetic backgrounds, diets, and environments, which is the vital next step in validating our phage-biosensors for prostate cancer detection.
🔗 Read more about our trip and what’s next
Aqsens Health’s team traveled to Shanghai to conduct prostate cancer analyses in collaboration with research teams from Nanjing and Shanghai. The goal of the trip was to analyze a large, well-designed urine sample cohort using the latest phage-biosensors. This collaboration combines Finnish biotec...